WESLEY FISHER: Open Payments
NPI 1033581467 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 31 payments from 14 companies in 2025. Trend: 2023 $721 · 2024 $831 · 2025 $623
Food & beverage: $592Education: $31
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $151 |
| Phathom Pharmaceuticals, Inc. | 4 | $77 |
| Janssen Biotech, Inc. | 4 | $74 |
| PFIZER INC. | 3 | $65 |
| Organon LLC | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| GENZYME CORPORATION | 1 | $31 |
| Braintree Laboratories, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $28 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
Products named: VOQUEZNA, TREMFYA, VELSIPITY, RINVOQ, CREON, ENTYVIO, DUPIXENT, SUFLAVE.
Industry payments across SC — which companies pay providers there.
